Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Groettrup

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
European Journal of Immunology|November 26, 2010
Immunoproteasomes are essential for survival and expansion of T cells in virus-infected miceJacqueline Moebius, Maries van den Broek, Marcus Groettrup, et al.
International Journal of Cancer|March 24, 2010
The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNAPeter Ohlschläger, Elmar Spies, Gerardo Alvarez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2012
Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiationKhalid W Kalim, Michael Basler, Christopher J Kirk, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 13, 2008
Quantitative analysis of gene expression relative to 18S rRNA in carcinoma samples using the LightCycler instrument and a SYBR GreenI-based assay: determining FAT10 mRNA levels in hepatocellular carcinomaSebastian Lukasiak, Kai Breuhahn, Claudia Schiller, et al.
Clinical and Experimental Rheumatology|October 13, 2015
The immunoproteasome: a novel drug target for autoimmune diseasesMichael Basler, Sarah Mundt, Annegret Bitzer, et al.
Molecular and Cellular Biology|April 16, 2005
FAT10, a ubiquitin-independent signal for proteasomal degradationMark Steffen Hipp, Birte Kalveram, Shahri Raasi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2010
Prevention of experimental colitis by a selective inhibitor of the immunoproteasomeMichael Basler, Maya Dajee, Carlo Moll, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
An altered T cell repertoire in MECL-1-deficient miceMichael Basler, Jacqueline Moebius, Laura Elenich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptorsDaniel F Legler, Petra Krause, Elke Scandella, et al.
Molecular Immunology|December 7, 2017
The 20S immunoproteasome and constitutive proteasome bind with the same affinity to PA28αβ and equally degrade FAT10Gunter Schmidtke, Richard Schregle, Gerardo Alvarez, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
European Journal of Immunology|November 26, 2010
Immunoproteasomes are essential for survival and expansion of T cells in virus-infected miceJacqueline Moebius, Maries van den Broek, Marcus Groettrup, et al.
International Journal of Cancer|March 24, 2010
The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNAPeter Ohlschläger, Elmar Spies, Gerardo Alvarez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2012
Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiationKhalid W Kalim, Michael Basler, Christopher J Kirk, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 13, 2008
Quantitative analysis of gene expression relative to 18S rRNA in carcinoma samples using the LightCycler instrument and a SYBR GreenI-based assay: determining FAT10 mRNA levels in hepatocellular carcinomaSebastian Lukasiak, Kai Breuhahn, Claudia Schiller, et al.
Clinical and Experimental Rheumatology|October 13, 2015
The immunoproteasome: a novel drug target for autoimmune diseasesMichael Basler, Sarah Mundt, Annegret Bitzer, et al.
Molecular and Cellular Biology|April 16, 2005
FAT10, a ubiquitin-independent signal for proteasomal degradationMark Steffen Hipp, Birte Kalveram, Shahri Raasi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2010
Prevention of experimental colitis by a selective inhibitor of the immunoproteasomeMichael Basler, Maya Dajee, Carlo Moll, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
An altered T cell repertoire in MECL-1-deficient miceMichael Basler, Jacqueline Moebius, Laura Elenich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptorsDaniel F Legler, Petra Krause, Elke Scandella, et al.
Molecular Immunology|December 7, 2017
The 20S immunoproteasome and constitutive proteasome bind with the same affinity to PA28αβ and equally degrade FAT10Gunter Schmidtke, Richard Schregle, Gerardo Alvarez, et al.
Pageof 14